Skip header and navigation

1 records – page 1 of 1.

Self-efficacy and compliance with benzodiazepine taper in older adults with chronic insomnia.

https://arctichealth.org/en/permalink/ahliterature174761
Source
Health Psychol. 2005 May;24(3):281-7
Publication Type
Article
Date
May-2005
Author
Lynda Bélanger
Charles M Morin
Céyne Bastien
Robert Ladouceur
Author Affiliation
Ecole de Psychologie, Université Laval, Québec, Canada. lynda.belanger@psy.ulaval.ca
Source
Health Psychol. 2005 May;24(3):281-7
Date
May-2005
Language
English
Publication Type
Article
Keywords
Aged
Benzodiazepines - therapeutic use
Chronic Disease
Female
Humans
Male
Middle Aged
Patient compliance
Quebec
Self Efficacy
Sleep Initiation and Maintenance Disorders - drug therapy
Abstract
Better understanding of compliance with BZD taper is warranted. Compliance with a taper program and perceived self-efficacy (SE) in being able to comply with hypnotic reduction goals was monitored weekly in 52 older adults (mean age: 63.0 years) with chronic insomnia (average duration: 21.9 years) who underwent a 10-week physician-supervised medication tapering. One group received cognitive- behavior therapy for insomnia during discontinuation, whereas the other did not. Compliant patients showed higher SE ratings at Weeks 6, 8, 9, and 10. Medication-free patients at the end of the treatment also reported higher mean SE ratings at those 4 weeks. Differences remained significant when withdrawal symptoms and sleep efficiency were controlled for. These results have important clinical implications because SE may indicate key time points when patients are experiencing more difficulty during discontinuation.
PubMed ID
15898864 View in PubMed
Less detail